# Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

> **NCT05705804** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 250 (estimated)

## Conditions studied

- Dyslipidemias
- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** Pitavastatin
- **DRUG:** Pitavastatin plus Ezetemibe
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT05705804
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-13
- **Primary completion:** 2025-02
- **Final completion:** 2025-04
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05705804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05705804, "Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05705804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*